Visualitza per autor "Mulet Margalef, Núria"
Ara mostrant els elements 1-4 d 4
-
BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer
Ros Montañá, Fco. Javier; Baraibar Argota, Iosune; Sardo, Emilia; Mulet Margalef, Núria; Salva Ballabrera, Francesc; Argilés Martinez, Guillem; Martini, Giulia; Ciardiello, Davide; Tabernero Caturla, Josep; Elez Fernandez, Mª Elena (SAGE Publications, 2021-01) -
Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS‐mutant metastatic colorectal cancer
Elez Fernandez, Mª Elena; Chianese, Chiara; Matito Ariza, Judit; Macarulla Mercadé, Teresa; Argilés Martinez, Guillem; Garcia Rodriguez, Ariadna; Mulet Margalef, Núria; Tabernero Caturla, Josep; Vivancos Prellezo, Ana; Sanz Garcia, Enrique; Martinelli, Erica; Noguerido Castro, Alba; Mancuso, Francesco Mattia; Caratù, Ginevra; Grasselli, Julieta; Martini, Giulia; Capdevila Castillon, Jaume (FEBS Press, 2019-07-31) -
Molecular subtypes and the evolution of treatment management in metastatic colorectal cancer
Martini, Giulia; Ros Montañá, Fco. Javier; Baraibar Argota, Iosune; Cuadra-Urteaga, Jose Luis; Salva Ballabrera, Francesc; Ciardiello, Davide; Mulet Margalef, Núria; Argilés Martinez, Guillem; Tabernero Caturla, Josep; Elez Fernandez, Mª Elena; Dienstmann, Rodrigo (SAGE Publications, 2020-07-24) -
Tumor-Associated Microbiome: Where Do We Stand?
Oliva, Marc; Mulet Margalef, Núria; Ochoa de Olza Amat, Maria; Napoli, Stefania; Mas Lloret, Joan; Laquente, Berta; Nuciforo, Paolo Giovanni (MDPI, 2021-02-01)